Variant report
Variant | esv1804844 |
---|---|
Chromosome Location | chr3:75961218-75986717 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FRG2C-12 | chr3:75986632-75986776 | NONHSAT090553 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531735481 | chr3:75963207-75963208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs78421858 | chr3:75963279-75963280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565270730 | chr3:75963300-75963301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186420112 | chr3:75963378-75963379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547890863 | chr3:75963393-75963394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9310351 | chr3:75963401-75963402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs536025946 | chr3:75963582-75963583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548485586 | chr3:75963586-75963587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552866512 | chr3:75963625-75963626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539060069 | chr3:75963654-75963655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71315323 | chr3:75963660-75963661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77614323 | chr3:75963672-75963673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4856024 | chr3:75963686-75963687 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs558168849 | chr3:75963690-75963691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373680205 | chr3:75963754-75963755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs715468 | chr3:75963778-75963779 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs552774401 | chr3:75963787-75963788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555206084 | chr3:75963852-75963853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572625054 | chr3:75963859-75963860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144415817 | chr3:75963887-75963888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188478353 | chr3:75963925-75963926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576851127 | chr3:75963947-75963948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs111244966 | chr3:75963966-75963967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565307991 | chr3:75964064-75964065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532537342 | chr3:75964089-75964090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568687626 | chr3:75964120-75964121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185842005 | chr3:75964193-75964194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565226040 | chr3:75982407-75982408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564864840 | chr3:75982432-75982433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34821214 | chr3:75982494-75982495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142558887 | chr3:75982547-75982548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7620543 | chr3:75982552-75982553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184589190 | chr3:75982583-75982584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190405422 | chr3:75982603-75982604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs117913749 | chr3:75982650-75982651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567759133 | chr3:75982664-75982665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111543872 | chr3:75982728-75982729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192897430 | chr3:75982755-75982756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185026147 | chr3:75982765-75982766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs578261219 | chr3:75982825-75982826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539315225 | chr3:75982854-75982855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554242098 | chr3:75982869-75982870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143258048 | chr3:75982871-75982872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572434660 | chr3:75982872-75982873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139857247 | chr3:75982892-75982893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs34740095 | chr3:75982982-75982983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561393624 | chr3:75982991-75982992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576450085 | chr3:75982994-75982995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149249140 | chr3:75983013-75983014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144427985 | chr3:75983033-75983034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:75963200-75964000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:75963600-75964200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr3:75964000-75964200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr3:75982400-75982600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr3:75982400-75982600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr3:75982600-75983200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr3:75982600-75983600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr3:75983200-75986800 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
9 | chr3:75983600-75984600 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
10 | chr3:75984800-75987000 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
11 | chr3:75985000-75985400 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
12 | chr3:75986400-75986800 | ZNF genes & repeats | NHLF | lung |
13 | chr3:75986600-75986800 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr3:75986600-75986800 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr3:75986600-75986800 | Enhancers | Esophagus | oesophagus |
16 | chr3:75986600-75986800 | ZNF genes & repeats | Fetal Brain Male | brain |
17 | chr3:75986600-75986800 | Enhancers | Gastric | stomach |
18 | chr3:75986600-75986800 | ZNF genes & repeats | Pancreas | Pancrea |
19 | chr3:75986600-75986800 | ZNF genes & repeats | Spleen | Spleen |